InfuSystem Holdings, Inc. (NYSEAMERICAN:INFU) Director Buys $28,520.00 in Stock

InfuSystem Holdings, Inc. (NYSEAMERICAN:INFU) Director Ralph F. Boyd, Jr. acquired 4,000 shares of the company’s stock in a transaction dated Thursday, May 23rd. The stock was purchased at an average cost of $7.13 per share, with a total value of $28,520.00. Following the completion of the purchase, the director now directly owns 6,000 shares of the company’s stock, valued at approximately $42,780. The acquisition was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

InfuSystem Stock Up 3.3 %

InfuSystem stock opened at $7.15 on Friday. InfuSystem Holdings, Inc. has a twelve month low of $6.25 and a twelve month high of $11.44. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.87 and a quick ratio of 1.51.

Wall Street Analysts Forecast Growth

INFU has been the subject of a number of research analyst reports. StockNews.com cut InfuSystem from a “strong-buy” rating to a “buy” rating in a report on Monday, May 13th. Lake Street Capital raised shares of InfuSystem to a “strong-buy” rating in a research note on Thursday, May 9th.

Institutional Trading of InfuSystem

Several hedge funds have recently added to or reduced their stakes in INFU. Vanguard Group Inc. grew its stake in shares of InfuSystem by 1.7% during the first quarter. Vanguard Group Inc. now owns 1,083,730 shares of the medical instruments supplier’s stock worth $9,288,000 after purchasing an additional 18,432 shares in the last quarter. Wasatch Advisors LP lifted its holdings in InfuSystem by 3.4% during the 4th quarter. Wasatch Advisors LP now owns 846,609 shares of the medical instruments supplier’s stock worth $8,923,000 after buying an additional 27,881 shares during the last quarter. Ranger Investment Management L.P. boosted its position in shares of InfuSystem by 4.7% during the 4th quarter. Ranger Investment Management L.P. now owns 689,842 shares of the medical instruments supplier’s stock worth $7,271,000 after acquiring an additional 30,835 shares in the last quarter. First Eagle Investment Management LLC increased its holdings in shares of InfuSystem by 12.7% in the 1st quarter. First Eagle Investment Management LLC now owns 605,235 shares of the medical instruments supplier’s stock valued at $5,187,000 after acquiring an additional 68,021 shares during the last quarter. Finally, Heartland Advisors Inc. raised its position in shares of InfuSystem by 17.6% during the 3rd quarter. Heartland Advisors Inc. now owns 500,000 shares of the medical instruments supplier’s stock worth $4,820,000 after acquiring an additional 75,000 shares in the last quarter. Institutional investors and hedge funds own 71.13% of the company’s stock.

InfuSystem Company Profile

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.